Delivery Order SPE2DR25D2206-SPE2DR26F9EM1
- Not listed
- The Defense Logistics Agency awarded a $8,313.12 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit of use packaging). This firm fixed-price contract, with a completion date of September 25, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30-count units, with a contract ceiling value of $1,385.52 and a completion date of October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at...
- The Defense Logistics Agency awarded a $8,313.12 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit dose) with an ultimate completion date of October 16, 2025. The contract is non-competitive with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) under a firm fixed-price contract valued at $5,840.52, with an ultimate completion date of December 17, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that serves as the primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-unit package) on October 22, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside contract has a ceiling value of $1,460.13 and is scheduled for completion by January 2, 2026. The order is priced on a firm fixed-price basis and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for supply of ORGOVYX 120 MG tablets in quantities of 30s, valued at $6,927.60 with a firm fixed price structure and completion deadline of September 29, 2025. This delivery order represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $26,282.34 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units). This is a firm fixed-price contract with an ultimate completion date of January 2, 2026, and no set-aside designation was utilized in the award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor fulfilling this order under its broader...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on September 22, 2025, with an ultimate completion date of October 14, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical supply to military...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EM1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-unit package) valued at $1,460.13 under a firm fixed price contract. This delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's engagement with the Defense Logistics Agency demonstrates its capacity to support military healthcare programs globally through flexible contract vehicles. This delivery order for ORGOVYX, a specialty pharmaceutical product, exemplifies the company's ongoing role in providing essential medications to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, through DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/3/25 |